Month: April 2021

The Effects of CSF Neurogranin and APOE ε4 on Cognition and Neuropathology in Mild Cognitive Impairment and Alzheimer’s Disease

Cerebrospinal fluid (CSF) measurements of neurogranin (Ng) have emerged as a promising biomarker for cognitive decline in mild cognitive impairment (MCI) and Alzheimer’s disease (AD). The apolipoprotein E ε4 (APOE ε4) allele is by far the most consistent genetic risk factor for AD. However, it is not known whether the pathophysiological roles of Ng in […]

Published on April 27, 2021

Cognitive and Structural Correlates of Conversational Speech Timing in Mild Cognitive Impairment and Mild-to-Moderate Alzheimer’s Disease: Relevance for Early Detection Approaches

Background: Increasing efforts have focused on the establishment of novel biomarkers for the early detection of Alzheimer’s disease (AD) and prediction of Mild Cognitive Impairment (MCI)-to-AD conversion. Behavioral changes over the course of healthy ageing, at disease onset and during disease progression, have been recently put forward as promising markers for the detection of MCI […]

Published on April 27, 2021

The Evolutionary History of Brains for Numbers

Humans and other animals share a ‘number sense’, an intuitive understanding of countable quantities. Having evolved independent from one another for hundreds of millions of years, the brains of these diverse species, including monkeys, crows, zebrafishes, bees, and squids, differ radically. However, in all vertebrates investigated, the pallium of the telencephalon has been implicated in […]

Published on April 27, 2021